Clinical Trial Update: Performance Evaluation of Dream OCT: AP Study

View source ↗

Summary

This clinical trial update reports on the Dream OCT AP study. Recruitment is ongoing for glaucoma and retinal patient populations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Retinal Diseases

Snippet

Sponsor: Intalight, Inc | Conditions: Glaucoma Patients, Retina Patients | Status: RECRUITING